Delivery Order W81K0225DA024-W81K0225FA149
Award Date 10/1/25
Potential Completion Date 9/30/26
Potential Value $72K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Tacoma, WA 98431, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order contract was awarded by the Defense Health Agency to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, laboratory instruments, and medical products. The $262,962.36 contract is for the supply of reagents and consumables to support the government-owned Roche b221 blood gas analyzers at Madigan Army Medical Center, Joint Base Lewis-McChord in Washington. The contract has a period of performance through September 30, 2025. This...
- This federal contract award is for $205,240.00 to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency under the Department of Defense, to provide automated immunohistochemistry (IHC) slide staining platforms, antibody stains, reagents, and supplies to support the Anatomic Pathology mission at Madigan Army...
- This federal contract award is for the delivery of required medical reagents to the Department of the Army Medical Command. The contract was awarded to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract has a potential value of $2,985,329.42 and is a Firm Fixed Price Delivery Order with no set-aside designation. Roche...
- This is a delivery order awarded by the Department of Defense's Medical Command to Roche Diagnostics Corporation for the provision of blood gas reagents and supplies. The contract, valued at $106,984.32, does not have a set-aside designation and was issued under Roche's existing General Services Administration (GSA) Schedule 65-VII contract for in vitro diagnostics, reagents, and test products. Roche Diagnostics, a manufacturer and distributor of medical laboratory equipment and consumables, has...
- The Department of the Army Medical Command awarded a $562,439 delivery order against Roche Diagnostics Corporation's GSA Schedule contract for in vitro diagnostics, reagents, and tests. The five-year order calls for Roche to provide reagents to Madigan Army Medical Center to support the Army medical facility's testing needs. As the prime contractor, Roche will fulfill the requirements for item 0005, delivering the necessary reagents. The contract was awarded on a firm-fixed price basis and...
- The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
- This federal contract award, valued at $246,187.68, was issued by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract provides supplies and consumables for the Anatomic Pathology Laboratory at Walter Reed National Military Medical Center. This is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type. The...
- Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a firm fixed price delivery order against an existing contract vehicle to provide laboratory detection kits to the Defense Health Agency. The $385,588.62 contract has no set-aside designation and requires completion by December 6, 2023. Roche will supply the kits from its location in San Diego, California in support of the Defense Health Agency's medical laboratory capabilities at military treatment...
- The Defense Health Agency awarded a $354,964.81 firm-fixed-price delivery order to Roche Diagnostics Corporation to provide test reagents for Fiscal Year 2023 from October 1, 2022 to September 30, 2023. The order was placed against one of Roche Diagnostics' existing Indefinite Delivery Contracts or Blanket Purchase Agreements with the federal government. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
- Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, was awarded a $39,235.49 firm fixed price blanket purchase agreement (BPA) call contract by the Department of the Army Medical Command on September 27, 2023. The contract has an anticipated completion date of October 6, 2023 and calls off of an existing BPA to supply laboratory instruments, reagents, test kits, and associated products and services in support of medical facilities located at Fort Meade, Maryland. As a...